Measurement of renal function in pre-ESRD patients

Slides:



Advertisements
Similar presentations
Parathyroidectomy: Whom and when?
Advertisements

Stephen P. McDonald, Graeme R. Russ  Kidney International 
Volume 54, Pages S135-S139 (December 1998)
Reduced renal function in patients with simple renal cysts
Volume 78, Issue 8, Pages (October 2010)
Pathophysiology of renal fluid retention
Volume 54, Issue 2, Pages (August 1998)
Anemia management in chronic kidney disease
Volume 83, Issue 3, Pages (March 2013)
Volume 68, Pages S52-S56 (December 2005)
Volume 78, Issue 8, Pages (October 2010)
Kidney transplantation in a low-resource setting: Nigeria experience
Parathyroidectomy: Whom and when?
Progression of renal failure and hypertensive nephrosclerosis
Pathophysiology of renal fluid retention
Francesco Paolo Schena  Kidney International 
George A. Kaysen, Burl R. Don
Anemia as a risk factor for chronic kidney disease
Volume 58, Issue 5, Pages (November 2000)
Comorbidity and confounding in end-stage renal disease
Insulin resistance in African Americans
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Edmund G. Lowrie  Kidney International 
Study of Heart and Renal Protection (SHARP)
Volume 73, Pages S5-S17 (April 2008)
Volume 70, Issue 12, Pages (December 2006)
Volume 67, Pages S48-S51 (January 2005)
Volume 54, Issue 2, Pages (August 1998)
Changes in the number of circulating TCM and TEM subsets in renal transplantation: relationship with acute rejection and induction therapy  David S. Segundo,
Peritoneal dialysis adequacy and risk of death
Martin K. Kuhlmann, Martina Heckmann, Werner Riegel, Hans Köhler 
New insights in uremic toxins
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 63, Pages S38-S42 (February 2003)
Non-immunologic intervention in chronic allograft nephropathy
Nephrology in Latin America, with special emphasis on Brazil
Alternate-day dialysis may be needed for hemodialysis patients
Juan M. Lopez-Gomez, Eduardo Verde, Rafael Perez-Garcia 
AGEs in foods: Do they play a role in uremia?
Reduced renal function in patients with simple renal cysts
Counteracting progression of renal disease: A look into the future
V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen 
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6?  Peter Stenvinkel, Peter Barany, Olof Heimbürger, Roberto Pecoits-Filho,
Volume 54, Pages S135-S139 (December 1998)
Homocysteine, renal function, and risk of cardiovascular disease
Volume 73, Issue 9, Pages (May 2008)
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Stephen P. McDonald, Graeme R. Russ  Kidney International 
Peritoneal dialysis in Mexico
Volume 63, Pages S79-S82 (June 2003)
Taking a public health approach to the prevention of end-stage renal disease: The NKF Singapore Program  Sylvia Paz B. Ramirez, Stephen I-Hong Hsu, William.
Clinical benefits of slowing the progression of renal failure
Organ transplantation goes to the movies
Return to dialysis after renal transplantation
Volume 53, Issue 5, Pages (May 1998)
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Charles A. Herzog  Kidney International 
Volume 62, Pages S68-S72 (December 2002)
Renal replacement therapy in Latin America
Volume 75, Issue 7, Pages (April 2009)
Volume 54, Issue 6, Pages (January 1998)
Renal vascular disease in the elderly
Relationship between advanced glycoxidation end products, inflammatory markers/acute-phase reactants, and some autoantibodies in chronic hemodialysis.
Volume 67, Issue 5, Pages (May 2005)
Recombinant hirudin (lepirudin) as anticoagulant in intensive care patients treated with continuous hemodialysis  Karl-Georg Fischer, M.D., Andreas van.
Morphology of the heart and arteries in renal failure
Asymmetric dimethylarginine: A cardiovascular risk factor in renal disease?  Danilo Fliser, Jan T. Kielstein, Hermann Haller, Stefanie M. Bode-Böger  Kidney.
Presentation transcript:

Measurement of renal function in pre-ESRD patients Emilio Rodrigo, Angel L. Martín De Francisco, Rafael Escallada, Juan C. Ruiz, Gema F. Fresnedo, Celestino Piñera, Manuel Arias  Kidney International  Volume 61, Pages S11-S17 (May 2002) DOI: 10.1046/j.1523-1755.61.s80.4.x Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 1 Relationships of measured creatinine clearance (A), Cockroft-Gault equation (B), and MDRD-7 equation (C) to weekly Kt/V in pre-ESRD patients. Regression lines are represented by solid lines. N = 1608 measurements of creatinine clearance and Cockroft-Gault. N = 321 measurements of MDRD-7. Kidney International 2002 61, S11-S17DOI: (10.1046/j.1523-1755.61.s80.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 2 Relationship of plasmatic creatinine to weekly Kt/V (weekly Kt/V < 2.5). Regression lines are represented by solid lines. N = 968 measurements. Kidney International 2002 61, S11-S17DOI: (10.1046/j.1523-1755.61.s80.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions

Figure 3 Relationships of averaged creatinine-urea clearance (A), and creatinine clearance (B) to nPNA in pre-ESRD patients. Regression lines are represented by solid lines. N = 1608 measurements. Kidney International 2002 61, S11-S17DOI: (10.1046/j.1523-1755.61.s80.4.x) Copyright © 2002 International Society of Nephrology Terms and Conditions